Rita Shridharani
Pediatric Endocrinology · Chattanooga, TNNPI 1740448067
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $827 and has fallen 52.0% since, to $397 in 2025.
Across 171 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$658
- Azurity Pharmaceuticals, Inc.$410
- Insulet Corporation$239
- Novo Nordisk$233
- Ultragenyx Pharmaceutical Inc.$202
- Xeris Pharmaceuticals, Inc.$178
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,68899%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $658 |
| Azurity Pharmaceuticals, Inc. | 14 | $410 |
| Insulet Corporation | 13 | $239 |
| Novo Nordisk | 11 | $233 |
| Ultragenyx Pharmaceutical Inc. | 2 | $202 |
| Xeris Pharmaceuticals, Inc. | 9 | $178 |
| Pfizer | 9 | $160 |
| Eton Pharmaceuticals, Inc. | 3 | $150 |
| Abbott | 7 | $142 |
| Sanofi-aventis U.S. LLC | 6 | $134 |
| Ascendis Pharma Endocrinology Inc | 6 | $122 |
| KARL Storz Endoscopy-america | 1 | $113 |
| Zealand Pharma US, Inc. | 6 | $111 |
| Arbor Pharmaceuticals, Inc. | 5 | $92 |
| Tandem Diabetes Care, Inc. | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| Dexcom, Inc. | 2 | $60 |
| Sequel Med Tech, LLC | 2 | $58 |
| Biomarin Pharmaceutical Inc. | 3 | $57 |
| Endo Pharmaceuticals Inc. | 3 | $55 |
| Ferring Pharmaceuticals Inc. | 3 | $54 |
| AstraZeneca | 3 | $51 |
| Lilly USA, LLC | 3 | $43 |
| Kyowa Kirin, Inc. | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| Rhythm Pharmaceuticals, Inc. | 2 | $28 |
| Mannkind Corporation | 1 | $26 |
| BETA Bionics, Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Tolmar Pharmaceuticals, Inc. | 1 | $21 |
| Lifescan, Inc. | 1 | $17 |
| Soleno Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,710 in reported general payments places this provider in the 65th percentile of 37 pediatric endocrinology providers in Tennessee.
Other pediatric endocrinology in Chattanooga
- Alexandra MartinChattanooga$3K
- Justin GregoryNashville$254K
- Nidhi GuptaFranklin$157K
- Ashley ShoemakerNashville$50K
- Jill SimmonsNashville$43K
- Daniel MooreNashville$32K
- George FordJohnson City$14K
- Leah AkinseyeMemphis$14K
- Ana KarabellMemphis$14K
- Evan LosJohnson City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.